EGF could increase the movement of HCC cells, especially transforming HCC cells from low to high metastatic capacity, through EGF-EGFR binding, PI3K and ERK signal pathway, or EGFR transactivation of CXCR2. Here, CXCR2 is linked to hepatocellular carcinoma.